Joint Formulary & PAD

Betamethasone - Mucositis - chemotherapy / radiotherapy induced

I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.

Status 1

Red
Formulations :
  • Soluble tablets
Associated Icons :
Restrictions / Comments :
Important
Patients on everolimus treatment. Used as a mouthwash, in line with St Luke's SACT protocols

Documentation

  • No records returned.

PAD Profile

ChemicalSubstance :
Betamethasone
Indication :
Mucositis - chemotherapy / radiotherapy induced
Group Name :
Keywords :
Oropharyngeal lesions, oral ulceration, oral inflammation
Brand Names Include :
Important Information :
Latest Additions Date From :
Latest Additions Date To :
Guidelines :
Supporting Documents :
0

Other Indications

Below are listed other indications that Betamethasone is used to treat.

Other Drugs

Below are listed other drugs that are used to treat Mucositis - chemotherapy / radiotherapy induced.

Committee Recommendations (1)

The Surrey Heartlands Area Prescribing Committee agreed the traffic light status of this drug and indication as part of the Joint Formulary review.